High Content Screening Applications for RNA Therapeutics
Bonnie J. Howell(Johns Hopkins University), Laura Sepp‐Lorenzino(Intellia Therapeutics (United States)), Michael Cerra(United States Military Academy), Amit Bahl(University of Georgia), Randy Crawford(United States Military Academy), Ansu Bagchi(Merck & Co., Inc., Rahway, NJ, USA (United States)), Irene Pak, Steven Krotzer(United States Military Academy), Wendy Bailey(United States Military Academy), Edward Keough(United States Military Academy)
Cited by 0
Related Papers
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
|New England Journal of Medicine|2021|1.7k
ToxoDB: an integrated Toxoplasma gondii database resource
|Nucleic Acids Research|2007|542
Total Synthesis of Spirotryprostatin A, Leading to the Discovery of Some Biologically Promising Analogues
|Journal of the American Chemical Society|1999|463
Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90
|Proceedings of the National Academy of Sciences|1996|409